Explain following terms: (I) Bioequivalence. (II) First pass clearance. (III) Relative bioavailability.
[6 marks]Explain physicochemical factors affecting bioavailability.
[5 marks]Enlist theories of dissolution and explain any one in detail.
[5 marks]What is TDM? Give its uses and recommendations.
[6 marks]Explain in brief collection and storage condition of body fluid samples.
[5 marks]Explain in detail radio immunoassay method.
[5 marks]Explain following techniques for in TDM of valproic acid: (I) Sample collection. (II) Time of sample collection.
[6 marks]Explain following techniques for in TDM of phenytoin: (I) Usual dosing parameters. (II) Clinical monitoring parameters.
[5 marks]Explain following techniques for in TDM of Immunosuppressants: (I) Common toxicities. (II) Drug reaction and interactions.
[5 marks]Explain in brief techniques for enhancing bioavailbility.
[6 marks]Write a short note on in vivo-in vitro correlation studies.
[5 marks]Enlist pharmocodynamic models. Explain any one in detail.
[5 marks]What are the criteria for selection of method for TDM? Explain in brief sample related parameters.
[6 marks]Enumerate elements of bioequivalence study protocol. Explain any one in detail.
[5 marks]Enlist physical methods used in TDM. Explain any one in detail. Q. 6 (a) Write a short note on role of clinical pharmacist in TDM.
[6 marks]Explain in detail ELISA Immuno assay.
[5 marks]What is the objective of BA studies?
[5 marks]Enumerate immunoassay methods used in TDM. Explain FPIA in details.
[6 marks]Give a full form of following terms: (I) HPLC (II) HPTLC (III) GC (IV) EMITH (V)TDM
[5 marks]Write a short note on study of clinical pharmacokinetics and importance parameters for lidocaine.
[5 marks]